Ehrlich Tumor Induces TRPV1-Dependent Evoked and Non-Evoked Pain-like Behavior in Mice [PDF]
Brain Sciences, 2022 We standardized a model by injecting Ehrlich tumor cells into the paw to evaluate cancer pain mechanisms and pharmacological treatments. Opioid treatment, but not cyclooxygenase inhibitor or tricyclic antidepressant treatments reduces Ehrlich tumor pain.
Mariana M. Bertozzi +13 more
doaj +2 more sources
Vochysia tucanorum Mart. butanol fraction presents antitumoral activity in vivo and prevents the installation of cachexia in solid Ehrlich tumor model [PDF]
BMC Complementary Medicine and Therapies, 2021 Background Cancer is a multifactorial disease caused by uncontrolled proliferation of cells. About 50–80% of cancer patients develop cachexia, a complex metabolic syndrome associated with an increase of mortality and morbidity.
Henrique Jorge Novaes Morgan +5 more
doaj +2 more sources
Quercetin Reduces Ehrlich Tumor-Induced Cancer Pain in Mice [PDF]
Analytical Cellular Pathology, 2015 Cancer pain directly affects the patient’s quality of life. We have previously demonstrated that the subcutaneous administration of the mammary adenocarcinoma known as Ehrlich tumor induces pain in mice.
Cassia Calixto-Campos +12 more
doaj +2 more sources
Ehrlich tumor inhibition using doxorubicin containing liposomes. [PDF]
Saudi Pharm J, 2015 Ehrlich tumors were grown in female balb mice by subcutaneous injection of Ehrlich ascites carcinoma cells. Mice bearing Ehrlich tumor were injected with saline, DOX in solution or DOX encapsulated within liposomes prepared from DMPC/CHOL/DPPG/PEG-PE (100:100:60:4) in molar ratio.
Elbialy NS, Mady MM.
europepmc +3 more sources
Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming [PDF]
PharmaceuticalsBackground/Objectives: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are a promising therapeutic avenue against mammary cancer.
Neveen R. Ashoura +8 more
doaj +2 more sources
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
Cells, 2021 Chronic myeloid leukemia (CML) has been a “model disease” with a long history. Beginning with the first discovery of leukemia and the description of the Philadelphia Chromosome and ending with the current goal of achieving treatment-free remission after ...
Valentina R. Minciacchi +2 more
doaj +1 more source
Asian Pacific Journal of Tropical Biomedicine, 2022 Objective: To assess the anti-tumor effects of Pistacia atlantica methanolic extract (PAME) compared with cyclophosphamide against Ehrlich solid tumors in mice.
Aishah E Albalawi +3 more
doaj +1 more source
Fagonia Arabica Extract Exerts Antitumor Effect on Mice Bearing Ehrlich Carcinoma [PDF]
Middle East Journal of Cancer, 2022 Background: To date, no studies have investigated the anticancer potential of Fagonia arabica. we aimed to investigate the antitumor potentiality and radiosensitizing effect of Fagonia arabica ethanolic extract (FAEE) on mice bearing solid ehrlich ...
Sanaa El-Benhawy +5 more
doaj +1 more source
Resistance against ehrlich ascites tumor induced by DEPC-treated Ehrlich cells. [PDF]
Agricultural and Biological Chemistry, 1975 The proliferating activity of Ehrlich ascites tumor cells decreased with the increase of the concentration of DEPC per 3 × 107 cells and disappeared at more than 200 μg. Sixty per cent of the mice immunized with 200 μg DEPC-treated Ehrlich cells twice survived the challenge inoculation.
Masayoshi Takakuwa +3 more
openaire +2 more sources
Advances in Antibody-Based HIV-1 Vaccines Development
Vaccines, 2020 Despite the great success of antiretroviral therapy, both in the treatment and prevention of HIV-1 infection, a vaccine is still urgently needed to end the epidemic [...]
Ursula Dietrich
doaj +1 more source